Literature DB >> 30072834

Diagnostic Potential of Circulating Biomarkers in Adenosine Deaminase Diagnosed Pleural Tuberculosis Cases.

Bineeta Kashyap1,2, Nisha Goyal1, N P Singh1, Iqbal R Kaur1.   

Abstract

Pleural tuberculosis accounts for nearly 20% of Extra pulmonary tuberculosis. Adenosine deaminase, commonly used biomarker for the diagnosis, is non specific and there is paucity of literature on its correlation with conventional or newer methods for the diagnosis of extra pulmonary forms of TB. The aim of the study was to assess diagnostic potential of T cell function markers [interferon (IFN-γ), interleukin (IL-2) and IFN-γ/IL-2 ratio]; macrophage activation marker [neopterin]; and oxidative stress markers [protein carbonyl and malondialdehyde (MDA)] in pleural tuberculosis. 26 pleural TB cases diagnosed on the basis of suggestive chest X-ray and raised serum ADA levels and healthy controls were included in the study. Pleural fluid specimens were subjected to Zeihl Neelsen staining and culture on Lowenstein Jensen medium. Serum IFN-γ, IL-2, neopterin and protein carbonyl levels detection were done by ELISA and MDA levels were determined by measuring the thiobarbituric acid reactive substances. Median serum levels of IFN-γ, IL-2, IFN-γ/IL-2 ratio, neopterin, protein carbonyl and MDA were significantly different between cases and controls. Levels of all biomarkers except IL-2 were significantly higher in cases with contact history. Mean levels of ADA and ESR were 46.27 U/L and 46.62 mm/hr in PTB cases. AUC for IFN-γ, IL-2, IFN-γ/IL-2 ratio, neopterin, protein carbonyl and MDA were significantly discriminative for cases and controls. IFN-γ/IL-2 ratio was best discriminatory biomarker with highest area under ROC curve. Though no correlation was seen between ADA and any of the six biomarkers, ESR levels correlated significantly with all biomarkers except IL-2 by spearman's correlation coefficient. Though all the circulating biomarkers under study provide useful supportive evidence for the diagnosis of PTB, further studies involving diverse control groups particularly non-PTB effusion are needed to validate these results.

Entities:  

Keywords:  ADA; Biomarkers; Pleural; Tuberculosis

Year:  2017        PMID: 30072834      PMCID: PMC6052732          DOI: 10.1007/s12291-017-0686-x

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Clinical practice. Pleural effusion.

Authors:  Richard W Light
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

3.  Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous.

Authors:  W W STEAD; A EICHENHOLZ; H K STAUSS
Journal:  Am Rev Tuberc       Date:  1955-04

Review 4.  Extrapulmonary tuberculosis.

Authors:  S K Sharma; A Mohan
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

Review 5.  Diagnosis and treatment of tuberculous pleural effusion in 2006.

Authors:  Arun Gopi; Sethu M Madhavan; Surendra K Sharma; Steven A Sahn
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

6.  Differentiating tuberculous from malignant pleural effusions: a scoring model.

Authors:  José Manuel Porcel; Manuel Vives
Journal:  Med Sci Monit       Date:  2003-05

Review 7.  Tuberculous pleural effusion.

Authors:  José M Porcel
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

8.  Tuberculous pleurisy: a study of 254 patients.

Authors:  L Valdés; D Alvarez; E San José; P Penela; J M Valle; J M García-Pazos; J Suárez; A Pose
Journal:  Arch Intern Med       Date:  1998-10-12

Review 9.  Tuberculous pleurisy: an update.

Authors:  Doosoo Jeon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

10.  Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study.

Authors:  Richard Meldau; Jonny Peter; Grant Theron; Greg Calligaro; Brian Allwood; Greg Symons; Hoosain Khalfey; Gina Ntombenhle; Ureshnie Govender; Anke Binder; Richard van Zyl-Smit; Keertan Dheda
Journal:  BMC Pulm Med       Date:  2014-04-08       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.